Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C17H25N3O.C6H8O7 |
| Molecular Weight | 479.5234 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC(=O)CC(O)(CC(O)=O)C(O)=O.CCC(C1=NOC(CCN(CC)CC)=N1)C2=CC=CC=C2
InChI
InChIKey=WFAULHLDTDDABL-UHFFFAOYSA-N
InChI=1S/C17H25N3O.C6H8O7/c1-4-15(14-10-8-7-9-11-14)17-18-16(21-19-17)12-13-20(5-2)6-3;7-3(8)1-6(13,5(11)12)2-4(9)10/h7-11,15H,4-6,12-13H2,1-3H3;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)
Proxazole Citrate is a spasmolytic papaverine-like agent used for functional gastrointestinal disorders in veterinary and acute renal insufficiency. In animal models, Proxazole has antitussive, antispasmodic, analgesic, anti-inflammatory, and antipyretic activities. Proxazole has veterinary uses against gastritis, infective and non-infective gastro-enteritis, urethritis, cystitis and spastic states with an inflammatory component of the smooth muscles of the digestive and genito-urinary systems. Proxazole is excreted both in feces and urine mainly as inactive metabolites.
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C29698
Created by
admin on Fri Dec 15 15:24:30 GMT 2023 , Edited by admin on Fri Dec 15 15:24:30 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
YR02IKM54O
Created by
admin on Fri Dec 15 15:24:30 GMT 2023 , Edited by admin on Fri Dec 15 15:24:30 GMT 2023
|
PRIMARY | |||
|
205-059-8
Created by
admin on Fri Dec 15 15:24:30 GMT 2023 , Edited by admin on Fri Dec 15 15:24:30 GMT 2023
|
PRIMARY | |||
|
m9282
Created by
admin on Fri Dec 15 15:24:30 GMT 2023 , Edited by admin on Fri Dec 15 15:24:30 GMT 2023
|
PRIMARY | Merck Index | ||
|
31363-11-8
Created by
admin on Fri Dec 15 15:24:30 GMT 2023 , Edited by admin on Fri Dec 15 15:24:30 GMT 2023
|
SUPERSEDED | |||
|
CHEMBL2106997
Created by
admin on Fri Dec 15 15:24:30 GMT 2023 , Edited by admin on Fri Dec 15 15:24:30 GMT 2023
|
PRIMARY | |||
|
19248-55-6
Created by
admin on Fri Dec 15 15:24:30 GMT 2023 , Edited by admin on Fri Dec 15 15:24:30 GMT 2023
|
NON-SPECIFIC STOICHIOMETRY | |||
|
8589
Created by
admin on Fri Dec 15 15:24:30 GMT 2023 , Edited by admin on Fri Dec 15 15:24:30 GMT 2023
|
PRIMARY | |||
|
132-35-4
Created by
admin on Fri Dec 15 15:24:30 GMT 2023 , Edited by admin on Fri Dec 15 15:24:30 GMT 2023
|
PRIMARY | |||
|
303872
Created by
admin on Fri Dec 15 15:24:30 GMT 2023 , Edited by admin on Fri Dec 15 15:24:30 GMT 2023
|
PRIMARY | |||
|
DTXSID5048760
Created by
admin on Fri Dec 15 15:24:30 GMT 2023 , Edited by admin on Fri Dec 15 15:24:30 GMT 2023
|
PRIMARY | |||
|
C152111
Created by
admin on Fri Dec 15 15:24:30 GMT 2023 , Edited by admin on Fri Dec 15 15:24:30 GMT 2023
|
PRIMARY |
PARENT (SALT/SOLVATE)
PARENT (SALT/SOLVATE)
SUBSTANCE RECORD
